S&P Futures
5,883.25 -13.00 (-0.22%) Dow Futures
43,101.00 -76.00 (-0.18%) Nasdaq Futures
20,451.75 -67.75 (-0.33%) Russell 2000 Futures
2,247.40 -8.10 (-0.36%) Crude Oil
70.50 -0.06 (-0.09%) Gold
2,751.00 +12.10 (+0.44%)
Acasti Pharma Inc. (ACST)
After hours:
| Previous Close | 3.3300 |
| Open | 3.4000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.1200 - 3.3882 |
| 52 Week Range | 1.9800 - 3.5900 |
| Volume | |
| Avg. Volume | 22,510 |
| Market Cap | 32.65M |
| Beta (5Y Monthly) | 1.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4300 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.97 |
GlobeNewswireAcasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
Data Readout Expected Early Calendar 2025; NDA Submission on Track for 1H Calendar 2025PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced that patient enrollment has been completed in the Company’s Phase 3 STRIVE-ON safety
GlobeNewswireLife Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held September 19th are now available for online viewing. This event was co-sponsored by Zacks Small-Cap Research. REGISTER NOW AT: https://bit.ly/3TuSFdy The company presentations will be available 24/
